Nippon Sanso Holdings Past Earnings Performance
Past criteria checks 5/6
Nippon Sanso Holdings has been growing earnings at an average annual rate of 16.3%, while the Chemicals industry saw earnings growing at 7.3% annually. Revenues have been growing at an average rate of 11% per year. Nippon Sanso Holdings's return on equity is 11%, and it has net margins of 8.7%.
Key information
16.3%
Earnings growth rate
16.3%
EPS growth rate
Chemicals Industry Growth | 6.6% |
Revenue growth rate | 11.0% |
Return on equity | 11.0% |
Net Margin | 8.7% |
Next Earnings Update | 31 Oct 2024 |
Recent past performance updates
Recent updates
Nippon Sanso Holdings Corporation Just Beat EPS By 6.5%: Here's What Analysts Think Will Happen Next
Aug 01Nippon Sanso Holdings (TSE:4091) Is Looking To Continue Growing Its Returns On Capital
Jul 25These 4 Measures Indicate That Nippon Sanso Holdings (TSE:4091) Is Using Debt Reasonably Well
Jun 04Is Now The Time To Put Nippon Sanso Holdings (TSE:4091) On Your Watchlist?
May 07Nippon Sanso Holdings (TSE:4091) Is Experiencing Growth In Returns On Capital
Apr 23Earnings Not Telling The Story For Nippon Sanso Holdings Corporation (TSE:4091)
Apr 10Nippon Sanso Holdings' (TSE:4091) Dividend Will Be ¥20.00
Mar 01Revenue & Expenses Breakdown
How Nippon Sanso Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 1,275,452 | 110,428 | 354,329 | 0 |
31 Mar 24 | 1,255,081 | 105,901 | 346,405 | 0 |
31 Dec 23 | 1,242,297 | 94,074 | 336,578 | 0 |
30 Sep 23 | 1,225,555 | 86,478 | 330,557 | 0 |
30 Jun 23 | 1,219,580 | 80,353 | 324,298 | 0 |
31 Mar 23 | 1,186,683 | 73,080 | 315,191 | 0 |
31 Dec 22 | 1,138,676 | 66,367 | 301,738 | 0 |
30 Sep 22 | 1,083,494 | 64,961 | 285,999 | 0 |
30 Jun 22 | 1,014,872 | 65,326 | 269,067 | 0 |
31 Mar 22 | 957,169 | 64,103 | 259,204 | 0 |
31 Dec 21 | 917,517 | 68,032 | 252,740 | 0 |
30 Sep 21 | 881,107 | 68,504 | 246,415 | 0 |
30 Jun 21 | 852,038 | 63,840 | 239,706 | 0 |
31 Mar 21 | 818,238 | 55,214 | 233,276 | 0 |
31 Dec 20 | 809,060 | 49,300 | 232,704 | 0 |
30 Sep 20 | 811,863 | 46,601 | 234,210 | 0 |
30 Jun 20 | 824,413 | 48,555 | 238,403 | 0 |
31 Mar 20 | 850,239 | 53,340 | 242,129 | 0 |
31 Dec 19 | 855,746 | 55,415 | 242,493 | 0 |
30 Sep 19 | 833,796 | 51,354 | 234,633 | 0 |
30 Jun 19 | 792,008 | 43,828 | 220,781 | 0 |
31 Mar 19 | 740,341 | 41,291 | 204,789 | 0 |
31 Dec 18 | 692,788 | 36,176 | 190,384 | 0 |
30 Sep 18 | 669,930 | 48,925 | 182,725 | 0 |
30 Jun 18 | 654,019 | 50,992 | 179,217 | 0 |
31 Mar 18 | 646,218 | 48,919 | 178,690 | 0 |
31 Dec 17 | 637,165 | 48,683 | 178,999 | 0 |
30 Sep 17 | 618,518 | 35,942 | 175,698 | 0 |
30 Jun 17 | 599,011 | 35,870 | 170,635 | 0 |
31 Mar 17 | 581,586 | 34,740 | 165,071 | 0 |
31 Dec 16 | 620,379 | 31,204 | 157,430 | 3,348 |
30 Sep 16 | 624,601 | 29,011 | 157,074 | 3,348 |
30 Jun 16 | 632,435 | 23,971 | 159,772 | 3,348 |
31 Mar 16 | 641,516 | 25,845 | 161,322 | 3,348 |
31 Dec 15 | 589,704 | 25,797 | 144,768 | 3,430 |
30 Sep 15 | 576,159 | 24,157 | 139,879 | 3,430 |
30 Jun 15 | 569,580 | 23,683 | 135,509 | 3,430 |
31 Mar 15 | 559,373 | 20,764 | 131,822 | 3,430 |
31 Dec 14 | 549,015 | 19,208 | 129,327 | 3,170 |
30 Sep 14 | 542,036 | 17,875 | 126,687 | 3,170 |
30 Jun 14 | 531,926 | 21,138 | 124,858 | 3,170 |
31 Mar 14 | 522,746 | 20,194 | 122,535 | 3,170 |
31 Dec 13 | 505,341 | 19,179 | 119,056 | 3,177 |
30 Sep 13 | 489,736 | 18,068 | 116,284 | 3,177 |
Quality Earnings: 4091 has high quality earnings.
Growing Profit Margin: 4091's current net profit margins (8.7%) are higher than last year (6.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4091's earnings have grown by 16.3% per year over the past 5 years.
Accelerating Growth: 4091's earnings growth over the past year (37.4%) exceeds its 5-year average (16.3% per year).
Earnings vs Industry: 4091 earnings growth over the past year (37.4%) exceeded the Chemicals industry 8.8%.
Return on Equity
High ROE: 4091's Return on Equity (11%) is considered low.